Abstract
Personal care products (PCP) often contain micron- or nano-sized formulation components, such as nanoemulsions or microscopic vesicles. A large number of studies suggest that such vesicles do not penetrate human skin beyond the superficial layers of the stratum corneum. Nano-sized PCP formulations may enhance or reduce skin absorption of ingredients, albeit at a limited scale. Modern sunscreens contain insoluble titanium dioxide (TiO2) or zinc oxide (ZnO) nanoparticles (NP), which are efficient filters of UV light. A large number of studies suggest that insoluble NP do not penetrate into or through human skin. A number of in vivo toxicity tests, including in vivo intravenous studies, showed that TiO2 and ZnO NP are non-toxic and have an excellent skin tolerance. Cytotoxicity, genotoxicity, photo-genotoxicity, general toxicity and carcinogenicity studies on TiO2 and ZnO NP found no difference in the safety profile of micro- or nano-sized materials, all of which were found to be non-toxic. Although some published in vitro studies on insoluble nano- or micron-sized particles suggested cell uptake, oxidative cell damage or genotoxicity, these data are consistent with those from micron-sized particles and should be interpreted with caution. Data on insoluble NP, such as surgical implant-derived wear debris particles or intravenously administered magnetic resonance contrast agents suggest that toxicity of small particles is generally related to their chemistry rather than their particle size. Overall, the weight of scientific evidence suggests that insoluble NP used in sunscreens pose no or negligible risk to human health, but offer large health benefits, such as the protection of human skin against UV-induced skin ageing and cancer.
This is a preview of subscription content, access via your institution.
Abbreviations
- GLP:
-
Good laboratory practice
- NP:
-
Nanoparticle(s)
- PCP:
-
Personal care product(s)/cosmetics
- PPS:
-
Primary particle size
- SC:
-
Stratum corneum
- TiO2 :
-
Titanium dioxide
- TTD:
-
Transdermal drug delivery
- ZnO:
-
Zinc oxide
References
Adachi K, Yamada N, Yamamoto K, Yoshida Y, Yamamoto O (2010) In vivo effect of industrial titanium dioxide nanoparticles experimentally exposed to hairless rat skin. Nanotoxicology 4(3):296–306
Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H (2004) Skin penetration and distribution of polymeric nanocapsules. J Contr Release 99(1):53–62
Arayachukeat S, Wanichwecharungruang SP, Tree-Udom T (2010) Retinyl acetate-loaded nanoparticles: dermal penetration and release of retinyl palmitate. Int J Pharm 404(1–2):281–288
Bennat C, Müller-Goymann CC (2000) Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int J Cosmetic Sci 22:271–283
Benson HAE (2005) Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2:23–33
BfR (2006). Bundesamt fuer Risikobewertung. Nanotechnologie und Lichtschutz. Available at: http://www.bfr.bund.de/cd/242
Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins RPF, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdoerster E (2006) The potential risks of nanomaterials: a review conducted out for ECETOC. Particle Fibre Toxicol 3:11
Bos JD, Meinardi MMHM (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9:165–169
Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM, Jacobs PM, Lewis JM (2005) Preclinical safety and pharmacokinetic profuile of ferrumoxtran-10, an ultrasmall supermagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41(3):313–324
Buesen R, Strauss V, Kaufmann W, van Ravenzwaay B (2009) Comparative study on the toxicity of nanoscale zinc oxides in Wistar rats after intravenous administration and observation period up to 4 weeks. BASF SE, Experimental Toxicology Department, Study No. OPPTS 870.7485, December 2009 (unpublished)
Ceve G, Vierl U (2010) Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Controll Release 141:277–299
Choi MJ, Maibach HI (2005) Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 18:209–219
Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P (2007) Human skin penetration of sunscreen nanoparticles: in vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 20:148–154
Dufour EK, Kumaravel T, Nohynek GJ, Kirkland D, Toutain H (2006) Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mut Res 607:215–244
Du Plessis J, Ramachandran C, Weiner N, Muller DG (1994) The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 103:277–282
Durand LN, Habran N, Henschel V, Amighi K (2009) In vitro evaluation of the cutaneous penetration of sprayable sunscreen emulsions with high concentrations of UV filters. Int J Cosmet Sci 31:279–292
Dussert A, Gooris E (1997) Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmet Sci 19:119–129
El Maghraby GM, Barry BW, Williams AC (2008) Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34(4–5):203–222
Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, Ravenszwaay B (2008) Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82(3):151–157
Filipe P, Silva JN, Silva R, Cirne de Castro JL, Marques Gomes M, Alves LC, Santus R, Pinheiro T (2009) Stratum corneum is an effective barrier to TiO 2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 22:266–275
Furukawa F, Doi Y, Suguro M, Morita O, Kuwahara H, Masunaga T, Hatakeyama Y, Mori F (2011) Lack of skin carcinogencity of topically applied titanium dioxide nanoparticles in the mouse. Food Chem Toxicol 40:744–749
Gamer AO, Leibold E, van Ravenzwaay B (2006) The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 20:301–307
Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Imhof V, Gehr P (2005) Ultrafine particles cross cellular membranes by non-phagocytotic mechanisms in lungs and in cultured cells. Environ Health Perspect 113(11):1555–1560
Gontier E, Habchi C, Pouthier T, Aguer P, Barberet P, Barbotteau Y, et al. (2004) Nuclear microscopy and electron microscopy studies of percutaneous penetration of nanoparticles in mammalian skin. 34th EDSR Meeting. Abstract 64
Gontier E, Ynsa MD, Biro T, Hunyadi J, Kiss B, Gaspar K, Pinheiro T, Silva JN, Filipe P, Stachura J, Dabros W, Reinert T, Butz T, Moretto P, Surlève-Bazeille JE (2008) Is there penetration of titania nanoparticles in sunscreens through skin? A comparative electron and ion microscopy study. Nanotoxicology 2(4):218–231
Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Warbritton AR, Yu WW, Colvin VL, Walker NJ, Howard PC (2007) Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 98(1):249–257
Gottbrath S, Müller-Goymann CC (2003) Penetration and visualization of titanium dioxide microparticles in human stratum corneumeeffect of different formulations on the penetration of titanium dioxide. SOFW J 129:11–17
Grassian VH, Adamcakova-Dodd A, Pettibone JM, O’Shaughnessy P, Thorne PS (2007) Inflammatory response of mice to manufactured titanium dioxide nanoparticles: comparison of size effects through different exposure routes. Nanotoxicology 1(3):211–226
Gulson B, McCall M, Korsch M, Gomez L, Casey P, Oytam Y, Taylor A, McCulloch M, Trotter J, Kinsley L, Greenoak G (2010) Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 118(1):140–149
Gunther C, Kecskes S, Staks T, Tauber U (1998) Percutaneous absorption of methylprednisolone aceponate following topical application of Avantan lotion on intact, inflamed and stripped skin of male volunteers. Skin Pharmacol Appl Skin Physiol 11(1):35–42
Hoet PHM, Brüske-Hohlfeld I, Sata OV (2004) Nanoparticles—known and unknown health risks. J Nanotechnol 2(12):1–15
Honeywell-Nguyen PL, Gooris GS, Bouwstra JA (2004) Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 123(5):902–910
Inman AO, Landsiedel R, Wiench K, Riviere JE, Schulte S, Monteiro-Riviere NA (2010) Assessment of UVB-damaged skin in vivo with sunscreen formulations containing Titanium and Zinc nanoparticles. Poster No. 2067 shown at SOT 2010 meeting, Salt Lake City, Utah, US, March 2010
Izquierdo P, Wiechers JW, Escribano E, Garcia-Celma MJ, Tadros TF, Esquena J, Dederen JC, Solans C (2007) A study on the influence of emulsion droplet size on the skin penetration of tetracaine. Skin Pharmacol Physiol 20(5):263–270
Jonaitis TS, Card JW, Magnuson B (2010) Concerns regarding nano-sized titanium dioxide dermal penetration and toxicity study. Toxicol Lett 192:268–269
Karlsson HL, Gustafsson J, Cronholm P, Muller L (2009) Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size. Toxicol Lett 188:112–118
Kertesz Z, Szikszai Z, Gontier E, Moretto P, Surleve-Bazeille JE, Kiss B, Juhasz I, Hunyadi J, Kiss AZ (2005) Nuclear microprobe study of TiO2-penetration in the epidermis of human skin xenografts. Nucl Instrum Methods Phys Res, Sect B 231:280–285
Kiss B, Bíró T, Czifra G, Tóth BI, Kertész Z, Szikszai Z, Kiss AZ, Juhász I, Zouboulis CC, Hunyadi J (2008) Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Exp Dermatol 17(8):659–667
Kogan A, Garti N (2006) Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123–126:369–385
Kuo TR, Wu CL, Hsu CT, Lo W, Chiang SJ, Lin SJ, Dong CY, Chen CC (2009) Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 30:3002–3008
Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W (1999) Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12:247–256
Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, Wohlleben W (2010) Testing metal-oxide nanomaterials for human safety. Adv Mater 22:2601–2627
Lekki J, Stachura Z, Dabros W, Stachura J, Menzel F, Reinert T, Butz T, Pallon J, Gontier E, Ynsa MD, Moretto P, Kertesz Z, Szikszai Z, Kiss AZ (2007) On the follicular pathway of percutaneous uptake of nanoparticles: ion microscopy and autoradiography studies. Nucl Instrum Methods Phys Res Sec B Beam Interact Mater Atoms 260:174–177
Lopez C (2005) Focus on the supramoleecular structure of milk fat in dairy products. Reprod Nutr Developm 45:497–511
Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, Konig K, Kostka KH, Lehr CM, Schaefer UF (2006) Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 4:190–197
Magnusson BM, Anissimov YG, Cross SE, Roberts MS (2004) Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 122:993–999
Mavon A, Miquel C, Lejeune O, Payre B, Moretto P (2007) In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 20:10–20
McLachlan SJ, Morris MR, Lucas MA, Fisco RA, Eakins MN, Fowler DR, Scheetz RB, Olukotun AY (1994) Phase I clinical evaluation of a new iron oxide MR contrast agent. JMRI 4:301–307
Menzel F, Reinet T, Vogt J, Butz T (2004) Investigations of percutaneous uptake of ultrafine TiO2 particles at the high energy ion nanoprobe LIPSION. Nucl Instr Meth Phys Res 220:82–86
Monteiro-Riviere NA, Wiench K, Landsiedel R, Schulte S, Champ S, Inman AO, Riviere JE (2010) In vitro penetration studies of sunscreen formulations containing Titanium and Zinc Nanoparticles. Poster No. 2068, US SOT 2010 meeting, Salt Lake City, Utah, US, March 2010
Nanoderm (2007) Quality of skin as a barrier to ultra-fine particles. Final report 1–55. Available at: http://www.uni-leipzig.de/~nanoderm/Downloads/Nanoderm_Final_Report.pdf
Newman MD, Stotland M, Ellis JI (2009) The safety of nanosized particles in titanium and zinc oxide-based sunscreens. J Am Acad Dermatol 61(4):685–692
Nohynek GJ, Dufour EK (2008) Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Appl Skin Physiol 21:136–149
Nohynek GJ, Lademann J, Ribaud C, Roberts MS (2007) Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37(1–27):2007
Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
Pflücker F, Wendel V, Hohenberg H, Gartner E, Will T, Pfeiffer S, Wepf R, Gers- Berlag H (2001) The human stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol Appl Skin Physiol 14:92–97
Pinheiro T, Allon J, Alves LC, Filipe P, Silva JN (2007) The influence of corneocyte structure on the interpretation of permeation profiles of nanoparticles across the skin. Nuclear Instrum Methods Phys Res B 260:119–123
Popov AP, Kirillin MY, Priezzhev AV, Lademann J, Hast J, Myllyla R (2005) Optical sensing of titanium dioxide nanoparticles within horny layer of human skin and their protecting effect against solar UV radiation. J. Biomed Optics 10(6):113–122
Sadrieh N, Wokovich AM, Gopee NV, Zheng J, Haines D, Parmiter D, Siitonen PH, Cozart CR, Patri AK, McNeil SE, Howard PC, Doub WH, Buhse LF (2010) Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles. Toxicol Sci 115(1):156–166
SCCP (2006) The SCCP’s notes of guidance for the testing of cosmetic ingredients and their safety evaluation. 6th Revision. 19 December 2006. Available at: http://ec.europa.eu/health/ph_risk/committees/
Schäfer-Korting M, Korting HC, Ponce-Paschal E (1994) Liposomal tretinoin for uncomplicated acne vulgaris. Clin Invest 72(12):1086–1091
Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, Pape W, Schulte S, Tooley I, van den Bosch J, Schellauf F (2010) Human safety review of “nano” titanium dioxide and zinc oxide. Photochem Photobiol Sci 9:495–509
Schins RP (2002) Mechanism of genotoxicity of particles and fibers. Inhal Toxicol 14(1):57–78
Schreier H, Bouwstra JA (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. Intern J Pharm 30:1–15
Schulz J, Hohenberg H, Pflücker F, Gärtner E, Will T, Pfeiffer S, et al. (2002) Distribution of sunscreens on skin. Adv Drug Deliv Rev 54(Suppl):S157–S163
Senzui M, Tamura T, Miura K, Ikarashi Y, Watanabe Y, Fujii M (2010) Study on penetration of titanium dioxide (TiO2) nanoparticles into intact and damaged skin in vitro. J Toxicol Sci 35(1):107–113
Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101(1):4–21
Tan MH, Commens CA, Burnett L, Snitch PJ (1996) A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 37:185–187
Theogaraj E, Riley S, Hughes L, Maier M, Kirkland D (2007) An investigation of the photo-clastogenic potential of ultrafine titanium dioxide. Mut Res 634(1–2):205–219
Tyner KM, Wokovich AM, Godard DE, Doudr WH, Sadrich N (2011) The state of nano-sized titanium dioxide (TiO2) may affect sunscreen performance. Intern J Cosm Sci 1–15. doi:10.1111/j.1468-2494.2010.006.22.x
US Environmental Protection Agency (2005) Nanotechnology workgroup/EPA’s science policy council. Nanotechnology white paper, 68–70, December 2, 2005. At: http://www.epa.gov/OSA/pdfs/EPA_nanotechnology_white_paper_external_review_draft_12-02-2005.pdf
Van den Bergh BAI, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA (1999) Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim Biophys Act 1461:155–173
Verma DD, Verma S, Blume G, Fahr A (2003) Particle size of liposomes influences dermal delivery of substances into the skin. Int J Pharm 258:141–151
Walker SL, Hawk JLM, Young AR (2003) Acute and chronic effects of ultraviolet radiation on the skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen FK, Goldsmith LA, Katz SI (eds) Fitzpatrick’s dermatology in general medicine, 6th edn. MacGraw-Hill: New York, USA. Chapter 134, pp 1275–1282
Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM (2007) Development of a base set of toxicity tests using ultrafine TiO2 particlesas a component of nanoparticle risk assessment. Toxicol Lett 171:99–110
Wu J, Liu W, Xue C, Zhou S, Lan F, Bi L, Xu H, Yang X, Zeng FD (2009) Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 191:1–8
Yu HY, Liao HM (1996) Triamcinolone permeation from different liposome formulations through rat skin in vitro. Int J Pharm 127:1–7
Zvyagin AV, Zhao X, Gierden A, Sanchez W, Ross JA, Roberts MS (2008) Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J Biomed Optics 13(06):064031
Acknowledgments
The authors of the article are employees of the personal care product industry. However, the opinions forwarded in the article represent their personal and independent opinions. In addition, the authors received no personal support or reward by their employer or the PCP industry for writing the article.
Conflict of interest
They therefore declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as a part of the Special Issue “Nanotoxicology II” on the ECETOC Satellite workshop, Dresden 2010 (Innovation through Nanotechnology and Nanomaterials + Current Aspects of Safety Assessment and Regulation.
Rights and permissions
About this article
Cite this article
Nohynek, G.J., Dufour, E.K. Nano-sized cosmetic formulations or solid nanoparticles in sunscreens: A risk to human health?. Arch Toxicol 86, 1063–1075 (2012). https://doi.org/10.1007/s00204-012-0831-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-012-0831-5